Gainers
- Bit Brother Limited (NASDAQ:BTB) rose 229% to $0.3688 after declining around 14% on Monday.
- Connexa Sports Technologies Inc. (NASDAQ:CNXA) gained 96% to $0.57. CONNEXA recently announced a $5.0 million private placement.
- Nocera, Inc. (NASDAQ:NCRA) rose 38% to $1.95. Nocera and VIE Meixin Institutional Food Development entered into distribution agreement with Farmers Vending Machine.
- AeroClean Technologies, Inc. (NASDAQ:AERC) shares climbed 37.8% to $4.41 after the company and Molekule announced they have entered into a definitive agreement to combine the companies in an all-stock merger.
- Humanigen, Inc. (NASDAQ:HGEN) gained 37% to $0.2449.
- Senti Biosciences, Inc. (NASDAQ:SNTI) rose 33.2% to $3.3300.
- Inhibrx, Inc. (NASDAQ:INBX) shares climbed 33% to $26.84 after the company announced that, based on discussions with the FDA, there is potential to pursue an accelerated approval in the U.S. for INBRX-101.
- Pulse Biosciences, Inc. (NASDAQ:PLSE) gained 24.8% to $2.76.
- Immunovant, Inc. (NASDAQ:IMVT) gained 22.5% to $8.07 after the company announced pricing of a $75 million underwritten offering of common stock.
- Blue Star Foods Corp. (NASDAQ:BSFC) climbed 21.7% to $1.01.
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 21.6% to $13.99 after gaining 14% on Monday.
- Borqs Technologies, Inc. (NASDAQ:BRQS) rose 21% to $0.8799. Borqs said its solar energy storage subsidiary recently signed an agreement to provide solar + energy storage systems to commercial and residential property in Hawaii.
- Autolus Therapeutics plc (NASDAQ:AUTL) jumped 19% to $2.5950. Autolus Therapeutics entered into an agreement with Bristol-Myers Squibb.
- Quantum-Si incorporated (NASDAQ:QSI) gained 18.4% to $3.27. Quantum-Si named Jeff Hawkins as Chief Executive Officer.
- 5E Advanced Materials Inc. (NASDAQ:FEAM) rose 18.2% to $12.59.
- The RealReal, Inc. (NASDAQ:REAL) surged 18% to $1.6999. RealReal inked a partnership with global luxury accessories brand Jimmy Choo.
- Kingsoft Cloud Holdings Limited (NASDAQ:KC) gained 18% to $2.30.
- Cue Biopharma, Inc. (NASDAQ:CUE) gained 18% to $2.8285. Cue Biopharma has been granted FDA Fast Track Designation for CUE-101 for the treatment of recurrent/metastatic head and neck squamous cell carcinoma.
- Blackbaud, Inc. (NASDAQ:BLKB) rose 17.3% to $52.78 after a 13D filing late Monday showed Clearlake Capital disclosed an 18.4% active stake in the company.
- Cloopen Group Holding Limited (NYSE:RAAS) jumped 16.8% to $0.88.
- Adeia Inc (NASDAQ:ADEA) rose 16.6% to $8.38 amid volatility as an independant company following Monday's spinoff from Xperi.
- Rackspace Technology, Inc. (NASDAQ:RXT) surged 15.7% to $4.7350.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) gained 15.5% to $1.2932.
- Borqs Technologies, Inc. (NASDAQ:BRQS) gained 15.5% to $0.8399.
- TDCX Inc. (NYSE:TDCX) jumped 14.3% to $10.59.
- CommScope Holding Company, Inc. (NASDAQ:COMM) gained 13.7% to $10.87 after Credit Suisse upgraded the stock from Neutral to Outperform and raised its price target from $11 to $17.
- Poshmark, Inc (NASDAQ:POSH) rose 13.4% to $17.66 after the company agreed to be bought by Korea's largest internet company, Naver Corp, for $17.90 per share in cash.
- Stitch Fix, Inc. (NASDAQ:SFIX) jumped 12.3% to $4.39.
- Core Scientific, Inc. (NASDAQ:CORZ) gained 12% to $1.5350 after Barclays initiated coverage on the stock with an Overweight rating and announced a $3 price target.
- Adeia Inc (NASDAQ:ADEA) rose 11.4% to $8.03 after Monday's spinoff of Xperi as an independent company.
- Grab Holdings Limited (NASDAQ:GRAB) gained 10.5% to $2.9850.
- Accolade, Inc. (NASDAQ:ACCD) gained 10.2% to $13.02. Piper Sandler maintained Accolade with an Overweight and raised the price target from $12 to $13.
- MFA Financial, Inc. (NYSE:MFA) rose 10% to $8.55.
- Smart for Life, Inc. (NASDAQ:SMFL) rose 9.9% to $0.4299.
- Bumble Inc. (NASDAQ:BMBL) gained 9.2% to $24.48. JP Morgan maintained Bumble with an Overweight and lowered the price target from $39 to $35.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 8.3% to $7.70 after jumping over 15% on Monday.
- Navitas Semiconductor Corporation (NASDAQ:NVTS) rose 8.3% to $5.51 after gaining 5% on Monday.
- DLocal Limited (NASDAQ:DLO) rose 8% to $23.03 after gaining 4% on Monday.
- Rivian Automotive, Inc. (NASDAQ:RIVN) rose 7.6% to $34.32 after the company issued an update on production and deliveries for the third quarter and said it remains on track to reach its previously provided production guidance. The company said it produced 7,363 vehicles and delivered 6,584 vehicles during the third quarter, its highest quarterly totals ever.
Losers
- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) shares fell 57% to $6.12 after the company announced it terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema.
- Oblong, Inc (NASDAQ:OBLG) fell 35.6% to $0.2573 after jumping 167% on Monday.
- FaZe Holdings Inc. (NASDAQ:FAZE) fell 33.6% to $5.41 after the company issued a filing showing issuance of up to roughly 5.92 million shares of common stock, the resale of up to roughly 64 million shares of common stock and the resale of roughly 173,000 warrants.
- FedNat Holding Company (NASDAQ:FNHC) shares fell 29.7% to $0.3301 after surging around 309% on Monday.
- Verastem, Inc. (NASDAQ:VSTM) dropped 25.2% to $0.6542 after the company announced RAMP VS-6766 clinical trials and corporate updates.
- Quanergy Systems, Inc. (NASDAQ:QNGY) fell 24.4% to $0.1592. Quanergy announced a 1-for-20 reverse stock split.
- FLJ Group Limited (NASDAQ:FLJ) dropped 18.2% to $1.5698.
- Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 17.9% to $15.16 after declining over 9% on Monday.
- AXT, Inc. (NASDAQ:AXTI) fell 17.8% to $5.76 after the company cut preliminary Q3 revenue guidance below estimates.
- Rallybio Corporation (NASDAQ:RLYB) dropped 17.8% to $12.21. Rallybio recently announced preliminary results from its ongoing Phase 1b proof-of-concept study of RLYB212 to prevent fetal and neonatal alloimmune thrombocytopenia.
- Athersys, Inc. (NASDAQ:ATHX) declined 15.5% to $1.85.
- MMTec, Inc. (NASDAQ:MTC) dropped 14.8% to $1.32.
- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) dropped 13.5% to $0.0178 after the company announced the NYSE has commenced delisting proceedings.
- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) declined 13.4% to $21.43. Maravai LifeSciences announced CEO leadership transition.
- Mondee Holdings, Inc. (NASDAQ:MOND) fell 11.3% to $7.80.
- Theratechnologies Inc. (NASDAQ:THTX) shares fell 10% to $2.0701. Theratechnologies announced FDA approval of Trogarzo for administration by IV push.
- Lottery.com Inc. (NASDAQ:LTRY) fell 7.2% to $0.28 after jumping 34% on Monday.
- Sportradar Group AG (NASDAQ:SRAD) dropped 6.6% to $8.18 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $14 to $8.
- Montauk Renewables, Inc. (NASDAQ:MNTK) declined 6% to $16.95.
